top line impress acut margin disappoint
ebitda est/consensu despit better expect rev
est/consensu margin basi point consensu
store ss acut rev remain strong come ss psych revenue
growth disappoint slow q/q lower price didnt expect
behavior segment improv immedi follow settlement doj
investig happen sequenti slowdown disappoint
meanwhil guidanc lower midpoint oper issu although
low end reiter impli quarter low end
compani intern expect said reiter buy rate strong
revenu import lt stori expect margin normal
time psych busi ramp
adj ep guid non-op item
weak print lower full year adj ep guid roughli
amount miss consensu adj ep adj ep includ
impact chang valu market secur mean
miss/guid due oper
ss margin y/i segment acut revenue strong
acut net rev estimate better adj admiss better
revs/adj admit howev ss margin y/i vs
behavior net rev estimate adj patient day
line estimate price estimate margin also weak declin
y/i flat ss opex high acut
busi often rapid growth lead extra cost temp labor meet demand
ss labor high psych busi weak revenu like creat neg
net dbt
strong revenue outweigh soft margin
psych tailwind still come
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
inc own oper
acut care hospit behavior health center
ambulatori surgeri radiat oncolog center
oper acut care hospit
behavior health facil us uk
believ pois see
reacceler psych busi
depart justic doj settlement
meanwhil exposur higher growth acut
care market allow perform better
averag wait psych rebound
po base ebitda estim repres multipl
compani histor rang ebitda reflect better expect
perform behavior busi higher earn exposur higher
growth/return psych busi today histor period averag
upsid risk po larger expect demand tailwind behavior
busi addit unexpect feder fund behavior health program
exposur faster expect growth acut busi
downsid risk po continu delay psych rebound rise labor cost
gener weak backdrop util rise bad debt
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
